SME · NSESubscribed: 7.11×
Chandan Healthcare Limited

Chandan Healthcare Limited

Chandan Healthcare Limited(CHANDAN)

Total Shares

67,52,000

Issue Size

₹107.36 Cr

Price Band

151 – ₹159

Lot Size

800 shares

Min. Investment

1,27,200

Max. Investment

1,27,200

Open Date

10 Feb, 2025

Close Date

12 Feb, 2025

Allotment

13 Feb, 2025

Listing

17 Feb, 2025

Announced

10 Feb, 2025

Opening Date

10 Feb, 2025

Closing Date

12 Feb, 2025

Basis of Allotment

13 Feb, 2025

Initiation of Refunds

14 Feb, 2025

Credit of Shares

14 Feb, 2025

Listing Date

17 Feb, 2025

Apply via UPI in 5 minutes

Choose your broker • Zero commission on IPO

About Chandan Healthcare Limited IPO

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services.

As of August 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 15 cities across Uttar Pradesh and over 10 in Uttarakhand.

As of August 31, 2024, the company offers 1,118 tests across different specialties. The test m

Chandan Healthcare Limited IPO Share Price and Issue Size

Issue Breakdown

Total Issue67,52,000 shares₹107.36 Cr
Fresh Issue44,52,064 shares₹70.79 Cr
Offer for Sale22,99,936 shares₹36.57 Cr

Shareholding

Pre-Issue2,00,00,000
Post-Issue0

Chandan Healthcare Limited IPO Financials Health

Chandan Healthcare Limited IPO Lot Size

ApplicationLotsSharesAmount
HNI Minimum216002,54,400
Retail Minimum18001,27,200
Retail Maximum18001,27,200

(All values in CR)

Chandan Healthcare Limited IPO Valuation

MetricValue
Debt/Equity1.02
PAT Margin9.26
ROCE35.04%
ROE47.60%
RoNW39.61%

(All values in CR)

Strength & Risk of Chandan Healthcare Limited IPO

+Strengths

1. Strong Geographical presence in Uttarakhand.

2. Integrated diagnostics provider with one-stop solution offering pathology and radiology testing, and medical consultation services.

3. Track record of profitability and consistent financial performance.

4. Dedicated management team with significant industry experience.

!Risks

1. Any interruptions at our flagship diagnostic centres may affect our ability to process diagnostic tests, which in turn may adversely affect our business, results of operations and financial condition.

2. Our business and prospects may be adversely affected if we are unable to maintain and grow our brand name and brand image.

3. We are dependent on B2C and few other customers for a major part of our revenues. Further we do not enter long-term arrangements with our customers and any failure to continue our existing arrangements could adversely affect our business and results of operations.

4. Any non-renewal or cancellation of our arrangements with our institutional customers, including hospitals, and government agencies may adversely affect our business, results of operations and financial condition.

5. Our operations are only focused on Uttar Pradesh and Uttarakhand, and any loss of business in such region could have an adverse effect on our business, results of operations and financial condition.

6. Our primary source of revenue is from our pathology and radiology services and our business may be adversely affected if these categories do not perform as well as expected.

7. We are dependent on our Group Company for a significant part of our revenues. Further we have not entered into any long-term arrangements with our group company i.e. Chandan Hospital Limited and any failure to deliver the commitment could adversely affect our business and results of operations.

8. We rely on domestic suppliers for the supply of medical consumables particularly suppliers from Uttar Pradesh and any delay, interruption or reduction in such supply could adversely affect our business, results of operations, financial condition and cash flows.

9. Our contingent liabilities as stated in our Restated Financial Statements could affect our financial condition.

10. We depend on third parties to provide us our reagents and films, and any failure to continue to do so or recall of existing testing equipment and reagents could adversely affect our business, results of operations and financial condition.

Chandan Healthcare Limited IPO Subscription Status

Investor CategorySubscription (times)Shares OfferedShares bid forTotal Amount (Rs Cr.)
Anchor1.0018,48,80018,48,80029.4
Employees0.212,45,60051,2000.81
HNI19.229,25,6001,77,91,200282.88
Market Maker1.003,39,2003,39,2005.39
QIB7.5812,33,60093,56,800148.77
Retail2.4421,59,20052,72,80083.84
Total7.1145,64,0003,24,72,000516.3

Chandan Healthcare Limited IPO GMP

00.0%

Last updated 05 Feb, 2025 · Source: aggregated grey-market dealers

DateIPO PriceGMPSub2 SaudaEst. ListingEst. ProfitUpdated
05 Feb, 2025159₹0--₹159 (0.00%)-05 Feb, 2025
06 Feb, 2025159₹148500₹173 (8.81%)-06 Feb, 2025
07 Feb, 2025159₹148500₹173 (8.81%)-07 Feb, 2025
10 Feb, 2025159₹84900₹167 (5.03%)-10 Feb, 2025
11 Feb, 2025159₹84900₹167 (5.03%)-11 Feb, 2025
12 Feb, 2025159₹31800₹162 (1.89%)-12 Feb, 2025
13 Feb, 2025159₹31800₹162 (1.89%)-13 Feb, 2025
17 Feb, 2025159₹0--₹159 (0.00%)-17 Feb, 2025

Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.

How to Apply for Chandan Healthcare Limited IPO

1

Login to Your Trading App

Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.

2

Go to IPO Section

Find Chandan Healthcare Limited under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).

3

Enter UPI ID and Submit

Provide your UPI ID linked to your bank account and submit the application.

4

Approve Mandate on UPI App

Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.

5

Application Confirmed

Your funds will be blocked in your account until the IPO allotment process is completed.